US-based medical device company Acelity has launched a new adjunctive non-surgical dressing, VAC Veraflo Cleanse Choice, that can be used to clean large complex wounds.

Combined with the firm’s negative pressure wound therapy and instillation (NPWTi-d) system called VAC Veraflo Therapy, the new dressing is expected to allow rapid cleansing when complete surgical debridement is not possible or appropriate.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The dressing comes with a three-layer foam design, enabling selective cleaning of affected tissue and infectious materials.

It features a contact layer designed to provide mechanical movement at the surface of the wound, as well as two cover layers that enable application on wounds with different depths.

“When considering treatment options for a severe wound, our aim is to provide clinicians and caregivers with greater certainty by offering the most robust and advanced portfolio of solutions.”

Acelity president and chief executive officer Joe Woody said: “When considering treatment options for a severe wound, our aim is to provide clinicians and caregivers with greater certainty by offering the most robust and advanced portfolio of solutions that includes industry-leading therapies and the unique service offerings that only Acelity provides.”

A clinical study was conducted on 21 patients to investigate the efficacy of the dressing.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The results showed that the combined dressing and VAC Ulta Therapy solution was able to loosen, solubilise, separate and eliminate viscous wound exudate from the wound.

This was found to be similar in cases of cleansing with or without surgical intervention.

When used for a complete treatment period with routine dressing changes, the dressing minimised the surface area of black non-viable tissue and yellow fibrinous slough.

The VAC Veraflo Cleanse Choice dressing is currently available in the US, Canada, Europe and Latin America.